Clinicians
Clinicians Home Consult Request Knowledge Base Education Catalog Centers Of Excellence
Individuals & Families
Guidance Knowledge Base Resources
Our Tools
Clozapine Dose Planner LAI Conversion Tool LAI Explorer
About Us
Contact

Search for:

∕
Knowledge Base (Clinicians)
∕
First Break Psychosis

Tag: First Break Psychosis

Knowledge Base (Clinicians)

135 result(s) found.

What are negative, positive, and disorganized symptoms of schizophrenia?
What is alogia, anhedonia, avolition, and affective flattening?
Do individuals with serious mental illness want their families involved in their care?
We have manualized evidence-based treatments, but no one uses them. How can we improve attendance rates?
What is Family Psychoeducation?
What are some techniques individuals can do to cope with psychotic symptoms?
Are there any reliable techniques to assess antipsychotic medication adherence?
What is patient-centered care?
What cognitive deficits are associated with schizophrenia? Are they stable over time?
What is social skills training?
What is cognitive remediation therapy?
What is Cognitive-Behavioral Therapy for Psychosis (CBTp)?
Persistent psychotic symptoms in schizophrenia
Cannabis Use and Psychosis in People with Schizophrenia
Antipsychotic Medication Continuation After Improvement in Schizophrenia
Education in people with serious mental illness
Employment of people with serious mental illness
Psychotherapy for People with Schizophrenia
What are some strategies and resources for addressing the first episode of a psychotic illnesses?
What is open dialogue?
What is psychosis?
If marijuana is legal, is it ok for patients with serious mental illness to use it?
Is peer support effective in working with people experiencing mental health crises?
Why is it common for people with serious mental illness to need more than one medication?
Fact Sheet: Trauma, PTSD and First Episode Psychosis
Addressing Trauma and PTSD in First Episode Psychosis Programs
Windows of Opportunity in Early Psychosis Care: Navigating Cultural Dilemmas
Information Brief: First-Episode Psychosis: Considerations for the Criminal Justice System
Educating Communities to Identify and Engage Youth in the Early Phases of an Initial Psychosis: A Manual for Specialty Programs
Fact Sheet: Supporting Student Success in Higher Education Beyond the Clinic
Issue Brief: What Comes After Early Intervention
Information Brief: Outreach for First Episode Psychosis
Issue Brief: Workforce Development in Coordinated Specialty Care Programs
Guidance Manual: Peer Involvement and Leadership in Early Intervention in Psychosis Services: From Planning to Peer Support and Evaluation
Fact Sheet: Building upon Existing Programs and Services to Meet the Needs of Persons with First Episode Psychosis
Fact Sheet: Implementation of Coordinated Specialty Services for First Episode Psychosis in Rural and Frontier Communities
Information Guide: Steps and Decision Points in Starting an Early Psychosis Program
Early Intervention in Psychosis: A Primer
Helping Families Understand Services for Persons with Early Serious Mental Illness: A Tip Sheet for Families
How can a patient know if a therapist is trained in Cognitive Behavioral Therapy?
Self-administered screening tools
Demystifying Psychosis: A Primer for Families
Issue Brief: Supported Education for Persons Experiencing a First Episode of Psychosis
Fact Sheet: Cognitive Behavioral Therapy for Psychosis (CBTp)
Issue Brief: Substance-Induced Psychosis in First Episode Programming
Issue Brief: Treating Affective Psychosis and Substance Use Disorders Within Coordinated Specialty Care
Family Involvement in Programming for Early Serious Mental Illness: A Tip Sheet for Clinicians
First Episode Psychosis – Fact Sheets
Navigating a Mental Health Crisis: Resource Guide and Infographics
Is weight gain or obesity a side effect of antipsychotic medications, and what can be done?
What are available practice guidelines for schizophrenia and early course psychosis?
What metabolic monitoring is appropriate when patients are taking antipsychotic medication? Are there any labs or vital signs to monitor?
What is known about research on antipsychotic medications and clozapine for schizophrenia in children and adolescents?
What metabolic monitoring is appropriate when patients are taking clozapine? Should we monitor weight, labs or vital signs?
Issue Brief: Understanding and Addressing the Stigma Experienced by People with First Episode Psychosis
Fact Sheet: Career Development
Supported Employment: Keys to a Successful Facility
Barriers to Employment for those with Severe Mental Illnesses
There’s More to Young Adult Unemployment Than Mental Health: What Else to Look For
Blueprint for Building Inter-Agency Collaboration through Strategic Planning: Supporting the Employment of Youth & Young Adults with Serious Mental Health Conditions
Making it Work: Vocational Peer Mentors for Emerging Adults with Serious Mental Health Conditions (2014)
First and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update
Interventions for Adult Offenders With Serious Mental Illness
Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression
Training Projects/Weight Management and Well-being
Early Psychosis Intervention
Management Strategies To Reduce Psychiatric Readmissions
How do I establish tolerability before starting a long-acting injectable antipsychotic medication (LAI), and how do I ensure the patient will not have side effects?
How can an individual improve their functioning despite having some cognitive problems?
Mental Health Criminal Justice Diversion
Wraparound for Older Youth and Young Adults
Understanding Neurobiology of Psychological Trauma: Tips for Working with Transition-age Youth
Supporting College Student Success Through Connections to Mentors and Campus Champions: A Strategy Brief For Campus-Based Mentors and Other Student Support Programs
Housing and Transition: Meeting the Needs of Young Adults with Mental Health Conditions
What is the best way to assess cognitive functioning in individuals with serious mental illness (SMI) without using a long battery of neurocognitive tests?
NAVIGATE Manuals
If an individual has a known neurological disorder, can the Cognitive Assessment Interview (CAI) still be used?
What is the difference between the various levels of Cognitive Assessment Interview (CAI) anchor points such as three, four, and five?
What if a clinician administers the Cognitive Assessment Interview (CAI) to an individual and a relative or family member is not available to be interviewed?
When administering the Cognitive Assessment Interview (CAI) may the clinician’s own follow-up questions be used?
Dealing with Psychosis: A Toolkit for Moving Forward with Your Life
Serious Mental Illness and Prolonged Youth Homelessness
First Episode Psychosis Resources: Focus on Effective Treatment Options
Working with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers
Providing Coordinated Specialty Care Services for First Episode Psychosis in Rural and Frontier Settings
Team-based Treatment for First Episode Psychosis is Cost Effective: Implications for Policy and Practice
Financing the Start-Up and Operation of First Episode Psychosis Programs
Back to School Support for Full Inclusion of Students with Early Psychosis in Higher Education, Campus Staff & Admin.
OnTrackNY Team Manuals
Best Practices in Continuing Care after Early Intervention for Psychosis
Online Tutorial: Facilitating Meaningful Engagement of Young People and Their Families in Early Intervention Programs
Partnering with the Justice System to Improve Outcomes in Coordinated Specialty Care
Webinar Part 1 & 2: Suicidal Ideation and Behavior in Individuals with a First Episode of Psychosis
Webinar: Non-Adherence and its Management in Early Course Psychotic Disorders
Webinar: La CLAVE to Reduce Treatment Delay in Latinos with First Episode Psychosis
TA Coalition Webinar: Serious Mental Illness/Substance Use Disorders and Tailoring FEP Programs to Serve Women
What are the best practices for transitioning an individual who had a first episode of psychosis to the next phase of care following the completion of a Coordinated Specialty Care (CSC) program?
Discontinuing Antipsychotic Medication after an Episode of Psychosis
Epidemiology of First Episode Psychosis in Large Integrated Healthcare Systems
When prescribing, what should I consider regarding doses of antipsychotic medications, oral or long-acting injectable medications?
First-Episode Psychosis and Co-Occurring Substance Use Disorders
Pathways Transition Training Toolkit, 2nd Ed: Self-Study Guide
Supporting Students Experiencing Early Psychosis in Middle School and High School
Learning Exchange Session: Incorporating Peer Workers into CSC Programs
Opportunities for Utilizing Peer Support and other Meaningful Peer Roles in Coordinated Specialty Care
Supported Education as a Component of Coordinated Specialty Care for Persons with First Episode Psychosis
Acceptance and Commitment Therapy for Early Psychosis
Practical Approaches to Measuring Fidelity in Coordinated Specialty Care for First Episode Psychosis
The Integration of Early Psychosis Services in a System of Care Framework: Opportunities, Issues, and Recommendations
Drop-in Centers as a Low-Barrier Engagement Strategy for Transition-Age Youth and Young Adults
NASMHPD’s webinar on Components of Coordinated Specialty Care for First Episode Psychosis: Guidance Related to the 5% Set-Aside in the Mental Health Block Grant
How can digital technology like smartphone apps help with care for patients at clinical high risk for psychosis or with first episode psychosis?
Ontario’s Early Psychosis Intervention Standards
What are the differences in prescribing antipsychotics for first episode psychosis versus other forms of psychosis?
What are the most important risk factors for relapse in individuals with first episode psychosis?
Navigating a Mental Health Crisis: Resource Guide and Infographics (Spanish Version)
First Episode Psychosis – Fact Sheets (Spanish Version)
What components of Coordinated Specialty Care (CSC) programs make this approach especially useful as a treatment for First Episode Psychosis (FEP)?
What are important considerations for the use of long-acting injectable (LAI) antipsychotic medications in first-episode psychosis patients?
Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains
What is generally known about recognizing and addressing suicidal ideation and behavior in individuals with a first episode of psychosis?
What are the risk factors for suicidal behavior in individuals with a first episode of psychosis and what are the protective factors?
For someone living with mental illness, could isolation and loneliness worsen their illness?
What is the difference between “proactive” and “reactive” suicide risk assessment and management of individuals with Serious Mental Illness (SMI)?
Resilience
How do you effectively work with someone who is experiencing paranoia?
Financing Coordinated Specialty Care for First Episode Psychosis: A Clinician/Advocate’s Guide
Clozapine & LAI Virtual Forum – November 2020 (Video) – Early psychosis and LAIs
Racial-Ethnic Disparities in Mental Health Care
Why is it helpful for an individual to find personal meaning from their experiences of psychosis?
Is it harmful to have too high of an expectation for recovery?
First Episode of Psychosis in Hispanic American Youth Challenges During a Pandemic
A Clinician’s Guide to First Episode Psychosis for LatinX Youth
Trauma and Serious Mental Illness
How can I learn more about person first language when speaking with someone with psychosis, their family or my colleagues?

Administered by

About SMI Adviser

Mission Statement

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need.

For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions.

For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

Terms & Privacy
Copyright

Sitemap

Clinicians
Individuals & Families
About
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2025 American Psychiatric Association. All rights reserved.